Search
for
Sort by
Research 181–210 of 376
- Exosomal Micro RNAs Derived from Dermal Papilla Cells Mediate Hair Follicle Stem Cell Proliferation and Differentiation
- Prostate Cancer Early Detection, Version 2.2015
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Targeting integrin pathways: mechanisms and advances in therapy
- Alopecia areata after dupilumab for atopic dermatitis
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model
- PROTACs: A novel strategy for cancer drug discovery and development
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Race and Alopecia Areata amongst US Women
- Update on hidradenitis suppurativa: connecting the tracts
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- The influence of interferon on healthy and diseased skin
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- CD80 on skin stem cells promotes local expansion of regulatory T cells upon injury to orchestrate repair within an inflammatory environment
- Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases
- Regulatory T cells in dominant immunologic tolerance
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Activation of TRPV3 Inhibits Lipogenesis and Stimulates Production of Inflammatory Mediators in Human Sebocytes—A Putative Contributor to Dry Skin Dermatoses
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Advances in regenerative medicine-based approaches for skin regeneration and rejuvenation
- Developing Human Skin Contains Lymphocytes Demonstrating a Memory Signature
- Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
- Estimated serum vitamin D status, vitamin D intake, and risk of incident alopecia areata among US women
- Fluoride exposure and pubertal development in children living in Mexico City
- Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders